Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2017-03-23 Director's Dealing
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2017-03-23 English
FORM 4 SUBMISSION
Director's Dealing
2017-03-21 English
FORM 3 SUBMISSION
Director's Dealing
2017-03-21 English
FORM 3 SUBMISSION
Director's Dealing
2017-03-21 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 21, 2017, reporting changes in the company's Board of Directors. It announces the appointment of two new directors and the departure of two others. The content focuses on management changes and does not contain financial statements or detailed financial performance data. The key section is Item 5.02, which specifically addresses departure and appointment of directors and officers. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 5475 characters, which is sufficient to contain substantive information rather than a mere announcement or certification. Hence, the classification is MANG with high confidence.
2017-03-21 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by AtriCure, Inc. It is a registration statement under the Securities Act of 1933 for the registration of securities to be offered under a stock incentive plan. The document includes legal and indemnification provisions, details about the securities to be registered, and references to other filings such as the Annual Report on Form 10-K. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Form S-8 is a specific SEC registration form for securities issued under employee benefit plans and is classified as a regulatory filing rather than a financial report or other category.
2017-03-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.